Premium
Neurocognitive, neuropsychiatric, and neurological outcomes associated with phenylalanine hydroxylase deficiency: Assessment considerations for nurse practitioners
Author(s) -
Lowe Tracy B.,
DeLuca Jane,
Arnold Georgianne
Publication year - 2021
Publication title -
journal for specialists in pediatric nursing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.499
H-Index - 38
eISSN - 1744-6155
pISSN - 1539-0136
DOI - 10.1111/jspn.12312
Subject(s) - neurocognitive , medicine , nurse practitioners , phenylalanine hydroxylase , disease , psychiatry , nursing , phenylalanine , cognition , health care , economics , economic growth , biochemistry , chemistry , amino acid
Purpose The purpose of this article is to review literature for neurocognitive, neuropsychiatric, neurological complications associated with phenylalanine hydroxylase (PAH) deficiency. The goal is to familiarize nurse practitioners with treatment and monitoring guidelines for persons living with the disorder. Conclusions Appropriate treatment can maximize neurocognitive and neuropsychiatric outcomes. Practice Implications Nurse practitioners can help persons with PAH deficiency through education and providing appropriate referrals and by supporting disease‐specific treatment.